Bristol-Myers Squibb Company (BMY) research: valuation against peers, fundamentals over time, risk and news coverage
BMY
Bristol-Myers Squibb CompanyNo data in this window.
Every report in our own archive tagged with this symbol, newest first — fetched from the archive alongside the market data.
- BREAKING STORYNEUTRALL3Harris Hands Leadership to Insider Sam Mehta as Kubasik Exits
L3Harris named insider Sam Mehta chief executive as Christopher Kubasik steps down, an orderly succession that points to strategic continuity at the defense contractor. The move lands alongside a broader wave of executive reshuffling across financials and healthcare, including Citigroup's appointment of Adam Clark as wealth planning head.
Every figure on this page is fetched and computed in your browser from free public sources — end-of-day prices and reported financials from Yahoo Finance's open endpoints, and our own archive for the coverage panel. Fundamental history on the free tier runs about four fiscal years and five quarters. Data is best-effort and unaudited; this is market research, not investment advice.